BLADEX, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data BLADEX, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2015	FY2017	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	0.43	168	138	128	127	99.2	104	167	266	304
General and administrative	7.47	7.47	6.85	6.39	4.14	3.06	4.48	5.59	6.17	7.11
Operating income	174	168	138	128	127	99.2	104	167	266	304
Net income	104	87	82	11.1	86.1	63.6	62.7	92	166	206
EPS, basic	2.67	2.23	2.09	0.28	2.17	1.60	1.62	2.54	4.55	5.60
EPS, diluted	2.66	2.22	2.08	0.28	2.17	1.60	1.62	2.54	4.55	5.60

Balance sheet

	FY2015	FY2017	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024
Cash and equivalents		1,070	672	1,746	1,178	864	1,253	1,242	2,047	1,964
Property, plant and equipment	6.17	8.55	7.42	6.69	18.8	16.2	17.8	17.3	16.8
Intangible assets	0.43	2.91	5.43	1.63	1.43	1.98	1.6	2.1	2.61	3.66
Total assets		7,181	6,268	7,609	7,250	6,289	8,038	9,284	10,744	11,859
Short-term debt		1,470	1,062	1,975	1,574	332	1,548	2,152	1,638	1,653
Lease liabilities					18.8	17.6	16.7	15.8	15.6	18
Total liabilities		6,169	5,225	6,616	6,233	5,251	7,046	8,215	9,540	10,521
Total debt	4,312	3,247	2,212	3,518	3,118	1,966	3,304	4,417	4,352	4,352
Retained earnings		588	480	423	446	464	488	544	673	792
Total equity	972	1,011	1,043	992	1,016	1,038	992	1,069	1,204	1,337
Total liabilities and equity		7,181	6,268	7,609	7,250	6,289	8,038	9,284	10,744	11,859

Cash flow statement

	FY2015	FY2017	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024
Net income	104	87	82	11.1	86.1	63.6	62.7	92	166	206
Cash from operations	419	784	716	-174	-92.4	1,247	-872	-770	1,062	-123
Capital expenditures	-0.62	-3.97	-2.65	-0.6	-1.03	-1	-0.45	-1.65	-0.76	-1.81
Cash from investing	130	148	10.2	-21.5	31.1	-320	-446	-167	-12.8	-180
Debt issued		406	220	609	372	828	267	1,038	496	1,192
Debt repaid		464	-883	-256	-369	-781	-97.5	-537	-221	-826
Share buybacks	0	0	-0.03	-2.44	0	0	-60.1	0	0
Dividends paid	-59.9	-60.1	-60.6	-61.5	-58.9	-44.7	-38.6	-36.1	-36.3	-72.8
Cash from financing	-23.6	-1,192	-1,115	1,282	-485	-1,241	1,683	916	-253	136
Net change in cash	526	-260	-389	1,087	-546	-314	365	-20.1	796	-167
Free cash flow	419	780	714	-174	-93.5	1,246	-872	-771	1,061	-124
Interest paid	72	91.8	107	139	174	91	53.3	140	412	533

Key metrics

Worked out from the statements above. Latest values use fiscal 2024. Valuation uses the share price of $54.74 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Operating margin	100.0%	Operating income / revenue.
Net margin	67.8%	Net income / revenue.
FCF margin	-41.0%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	-40.4%	Cash from operations / revenue.
Return on assets (ROA)	1.8%	Net income / average total assets.
Capex / revenue	0.6%	Capital expenditures / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	14.1%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	42.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	19.1%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	14.1%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	42.8%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	19.1%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	23.9%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	48.6%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	19.1%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	23.1%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	51.2%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	20.9%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-111.5%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y	-111.7%	Free cash flow vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y	10.4%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	13.8%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	10.3%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.

Balance sheet health

Metric	Value	How it is calculated
Debt / assets	36.7%	Total debt / total assets.
Liabilities / assets	88.7%	Total liabilities / total assets.
Net debt	$2.39B	Total debt - cash - short-term investments. Negative means more cash than debt.
Goodwill and intangibles / assets	0.0%	(Goodwill + intangible assets) / total assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.03x	Revenue / average total assets.
FCF conversion	-60.5%	Free cash flow / net income, when net income is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$5.60	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	$5.60	Net income per basic share, as reported (split-adjusted).
Payout ratio	35.4%	Dividends paid / net income, when net income is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$2.06B	Share price x shares outstanding.
Enterprise value	$4.45B	Market cap + total debt - cash - short-term investments.
P/E	10.00x	Market cap / net income. Only when net income is positive.
P/S	6.78x	Market cap / revenue.
EV/Sales	14.6x	Enterprise value / revenue.
EV/EBIT	14.6x	Enterprise value / operating income, when both are positive.
FCF yield	-6.0%	Free cash flow / market cap.
Earnings yield	10.0%	Net income / market cap (the inverse of P/E).
Dividend yield	3.5%	Dividends paid over the period / market cap.
Shareholder yield	3.5%	(Dividends paid + share buybacks) / market cap.
PEG	0.20x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was BLADEX, INC.'s revenue in fiscal 2024?

BLADEX, INC. reported revenue of $303.6M for fiscal 2024, 14.1% higher than the year before.

Was BLADEX, INC. profitable in fiscal 2024?

Yes. Net income was $205.9M, a net margin of 67.8%.

How much free cash flow did BLADEX, INC. generate in fiscal 2024?

Cash from operations of $122.7M minus capital expenditures of $1.8M left free cash flow of -$124.5M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to BLADEX, INC.